# A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Study · id `cardio:ct-nct07340320` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07340320](<https://clinicaltrials.gov/study/NCT07340320>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07340320

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 251 participants.

## Technical summary

Registry record NCT07340320. Randomized; double masking; primary purpose treatment. Start 2026-02-06 (actual); primary completion 2027-04-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 251 participants (enrolled count; ClinicalTrials.gov record NCT07340320, source copy `cardio:ctgov-nct07340320-2026-11-10`, retrieved 2026-11-18)
- Started: 2026-02-06 (actual) (ClinicalTrials.gov record NCT07340320, source copy `cardio:ctgov-nct07340320-2026-11-10`, retrieved 2026-11-18)
- Primary completion: 2027-04-08 (anticipated) (ClinicalTrials.gov record NCT07340320, source copy `cardio:ctgov-nct07340320-2026-11-10`, retrieved 2026-11-18)
- Completion: 2027-04-15 (anticipated) (ClinicalTrials.gov record NCT07340320, source copy `cardio:ctgov-nct07340320-2026-11-10`, retrieved 2026-11-18)
- Countries: United States; Poland (ClinicalTrials.gov record NCT07340320, source copy `cardio:ctgov-nct07340320-2026-11-10`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07340320-2026-11-10`, retrieved 2026-11-18)

## The registry's words

- Brief title: A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Condition: Type II Diabetes Mellitus
- Intervention (Drug): CX11
- Intervention (Other): Placebo
- Lead sponsor: Corxel Pharmaceuticals
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Corxel Pharmaceuticals (`cardio:org-corxel-pharmaceuticals`)

## Provenance

Content hash: d5b2ce603a98c5bd58a6b658dd1af799bfac9b00c597d78c2f154847b1f06988
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
